#United States #New York #FDA Approval #Health Press #Diabetes Awareness

Weekly Roundup of Key Health Developments

The week of January 20-24, 2025, brought several noteworthy updates in the health sector. Among the various press releases, here are some highlights that should not be overlooked:

SPRAVATO® Approved for Treatment-Resistant Depression

The FDA has granted approval to SPRAVATO® (esketamine), marking it as the first and sole monotherapy available for adults struggling with treatment-resistant depression. This significant decision followed a Priority Review and was supported by results from a robust clinical trial demonstrating that patients experienced marked improvements in depressive symptoms as quickly as 24 hours post-treatment compared to placebo.

Handwashing Against Norovirus

The Centers for Disease Control and Prevention (CDC) has issued an advisory stressing that traditional alcohol-based hand sanitizers are ineffective in combating norovirus. Health experts recommend handwashing with soap and water as the paramount defense to prevent its spread, which is crucial information for public health campaigns.

National Blood Clot Alliance Initiatives

In a proactive effort to address healthcare disparities, the National Blood Clot Alliance has launched its first-ever B.L.A.C.K. Church Bus Tour. This initiative focuses on increasing awareness around blood clots in Black communities, utilizing local churches as trusted venues for delivering important health education.

AbbVie Expands Immunology Pipeline

AbbVie successfully completed its acquisition of Nimble Therapeutics, which enriches its immunology product pipeline with new oral peptide assets. Jonathon Sedgwick, senior vice president at AbbVie, emphasized the potential for innovation within their research and development capabilities following this acquisition.

TriVerity™ Test Receives FDA Clearance

Inflammatix has achieved FDA clearance for its TriVerity™ test, a pioneering molecular blood test that distinguishes between bacterial and viral infections. This advancement is anticipated to streamline emergency departmental operations by aiding timely medical decisions in critical situations.

American Diabetes Association's Collaboration

In collaboration with Xeris Pharmaceuticals, the American Diabetes Association aims to enhance awareness and education surrounding hypoglycemia. They intend to address the lack of glucagon prescriptions, a critical lifesaving treatment for those living with diabetes, through comprehensive training resources for healthcare professionals.

New Pediatric Clinical Pharmacology Community

The American College of Clinical Pharmacology has launched a new community focused on pediatric and maternal health. This initiative intends to advocate for clinical pharmacology's best practices and align US healthcare education with global standards.

University of Melbourne's Research on Neurodivergent Learners

A joint study by the University of Melbourne and SMART Technologies has produced groundbreaking recommendations for supporting neurodivergent learners through technology. This initiative outlines effective strategies for educational leaders aimed at inclusivity and improved educational outcomes.

Iris Telehealth Expands Telepsychiatry Services

Iris Telehealth's acquisition of innovaTel signals its dedication to enhancing telepsychiatry services. This initiative is pivotal in increasing accessibility to behavioral health support amid the growing demand for mental health resources.

Inspira™ Technologies' Launch

Inspira™ has prepared its life-support systems for deployment at a leading New York hospital. The INSPIRA™ ART100 cardiopulmonary bypass systems mark a significant step in advancing surgical care capabilities across the U.S.

Global Initiative Against Sickle Cell Disease

The Bristol Myers Squibb Foundation, along with Texas Children's Global HOPE and Baylor College of Medicine, is launching a program aimed at tackling sickle cell disease in sub-Saharan Africa. Planned strategies focus on building local healthcare capacity and implementing essential lifesaving interventions.

ALS Association's Advocacy Report Cards

The ALS Association has released State Advocacy Report Cards, showcasing states that excel in legislative support for ALS patients while identifying areas needing improvement. This initiative aims to ensure comprehensive care and support for individuals living with ALS.

Americans Reducing Alcohol Consumption

As reported by NCSolutions, nearly half of Americans plan to decrease their alcohol consumption in 2025, with around 30% already committing to participate in Dry January. This shift marks a growing trend in prioritizing wellness.

Inhibrx's Promising Trial Results

Inhibrx Biosciences showcases preliminary data from its Phase 1 trial of ozekibart (INBRX-109) for treating colorectal cancer, with optimistic interim results highlighting its potential benefits for advanced solid tumor patients.

These developments reflect an active week in the healthcare industry, with discoveries and initiatives continuing to shape public health and clinical practices. For more detailed insights into these topics, please visit the respective press releases.

• ---

To keep connected with relevant health news and updates, journalists can sign up for customized newsfeeds with PR Newswire, gaining access to a wealth of multimedia resources and expert insights that can enhance their reporting capabilities.